Cargando…
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
Biologics have advanced the therapy of adult and pediatric arthritis. They have been linked to rare serious adverse outcomes, but the actual risk of these events is controversial in adults, and largely unknown in pediatrics. Because of the paucity of safety and efficacy data in children, pediatric r...
Autores principales: | Stoll, Matthew L, Gotte, Alisa C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721362/ https://www.ncbi.nlm.nih.gov/pubmed/19707357 |
Ejemplares similares
-
Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
por: Gotte, Alisa Carman
Publicado: (2009) -
Treatment of juvenile idiopathic arthritis: a revolution in care
por: Stoll, Matthew L, et al.
Publicado: (2014) -
Eight years of experience with biological treatment in juvenile idiopathic arthritis
por: Mourão, A F, et al.
Publicado: (2010) -
Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012) -
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
por: Choida, Varvara, et al.
Publicado: (2021)